Comparison of four high-throughput, automated immunoassays for the detection of SARS-CoV-2 antibodies

Author(s) Oakey J.; Haslam S.; Houghton B.; Brown A.; Eglin J. et al.
Source Annals of Clinical Biochemistry; 2021
Background: A number of immunoassays have been developed to measure antibodies specific to SARS-CoV-2. More data is required on their comparability, particularly among those with milder infections and in the general practice population. The aim of this study was to compare four high-throughput automated anti-SARS-CoV-2 assays using samples collected from hospitalized patients and healthcare workers with confirmed SARS-CoV-2 infection. In addition, we collected general practice samples to compare antibody results and determine seroprevalence. 

• Available in full text from SAGE Journals